Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etofenamate spray for post-cesarean section pain
PACTR201811864509898Phase 4Completed
- Sponsor
- Mogadishu Somali Turkey Recep Tayyip Erdogan Training and Research Hospital
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of etofenamate in postoperative pain (2 arms), sponsored by Mogadishu Somali Turkey Recep Tayyip Erdogan Training and Research Hospital. Primary endpoints: Postoperative pain intensity and Rescue analgesic use. Started Nov 2018; status: completed.
02
Drugs
etofenamate
03
Conditions
postoperative pain
Beyond the preview
Go deeper on PACTR201811864509898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201811864509898.